[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Unger et al., 1975 - Google Patents

Disruption of the blood-aqueous barrier following paracentesis in the rabbit

Unger et al., 1975

Document ID
15366821615027752119
Author
Unger W
Cole D
Hammond B
Publication year
Publication venue
Experimental Eye Research

External Links

Snippet

The concentrations of protein and prostaglandin are greatly elevated in aqueous humour secondary to anterior chamber paracentesis in the rabbit. A transient increase of intraocular tension which follows paracentesis is mediated by prostaglandin and the breakdown in the …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes

Similar Documents

Publication Publication Date Title
Unger et al. Disruption of the blood-aqueous barrier following paracentesis in the rabbit
Butler et al. The effects of sensory denervation on the responses of the rabbit eye to prostaglandin E1, bradykinin and substance P.
Mermoud et al. Comparison of deep sclerectomy with collagen implant and trabeculectomy in open-angle glaucoma
ASHTON et al. Effect of histamine on the permeability of the ocular vessels
Irvine Cystoid maculopathy
US6586425B2 (en) Cytoskeletal active agents for glaucoma therapy
Zimmerman et al. The effect of suture depth on outflow facility in penetrating keratoplasty
US20100197788A9 (en) Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
Unger et al. The response of the rabbit eye to laser irradiation of the iris
US8097640B2 (en) Prophylactic or therapeutic agent for diabetic maculopathy
Ebneter et al. Novelties in diabetic retinopathy
Kahook et al. Chandler and Grant's Glaucoma
Whitelocke et al. Prostaglandins and the Eye: Acute Anterior Uveitis and Prostaglandins
Roth et al. Ocular pathologic changes in primary hemochromatosis
Cole et al. Action of bradykinin on intraocular pressure and pupillary diameter
HEATH et al. Use of Phenylephrine Hydrochloride (Neo-Synephrine Hydrochloride®) in Ophthalmology
Jolliffe et al. A comparison of topical anaesthesia and retrobulbar block for cataract surgery
Rodger The pathogenesis and pathology of ocular onchocerciasis
STILLERMAN Ocular manifestations of diffuse collagen disease
Radius Optic nerve fast axonal transport abnormalities in primates: occurrence after short posterior ciliary artery occlusion
Tolentino et al. Toxicity of intravitreous miconazole
KR100287991B1 (en) Ophthalmic Argatroban Formulations
Tamura Neovascularization in experimental retinal venous obstruction in rabbits
SLANSKY et al. Ciliary body cysts in multiple myeloma: Their relation to urethane, hyperproteinemia, and duration of the disease
Tian et al. Acute effects of H-7 on ciliary epithelium and corneal endothelium in monkey eyes